Email:
Tel: 
The main reason for using next-generation sequencing is the effective reduction in turnaround time with NGS compared to traditional methods. At the same time, next-generation sequencing makes it possible to analyze the transcriptome and genome of a species in a detailed and holistic way. CD BioSciences offers a growing range of services, from library construction to sequencing to complete experimental design and support. Our Illumina iSeq 100 Next Generation Sequencer-based next-generation sequencing technology can help you advance genome engineering innovation.
It is capable of producing 8M reads per run and can be run in read lengths of:
• 1 × 36 bp
• 1 × 50 bp
• 1 × 75 bp
• 2 × 75 bp
• 2 × 150 bp
The iSeq is a next generation sequencing device made by Illumina Inc. It is the smallest instrument in the fleet of Illumina sequencers capable of producing small data sets and is thus reduces the cost per sample compared to a NextSeq500 sequencer for bacterial genome/transcriptome sequencing, targeted sequencing, and viral genome sequencing.
CD BioSciences, as a specialist sequencing company, has a large range of sequencers in our NGS Core, including Illumina MiSeq, NovaSeq, PacBio, and more. If you require this service, please contact us directly.
Please fill out the form below and we will get back to you as soon as possible with a quotation for the item you are interested in.
CD BioSciences is committed to providing a tailored service to researchers working in the fields of biology and chemistry. Our mission is to accelerate the progress of your research through our technical support.